Retinal disease diagnosis in seconds
Retinix analyzes OCT images, localizes biomarkers on retinal layers, and generates a second opinion report. Integrates into the clinic's workflow without replacing equipment.
Real-world efficiency
Results of the Retinix AI platform in medical centers during pilot implementation.
How it works
Three steps from image to finished report. Integrates with existing clinic equipment.
Detailed analysis of 24 biomarkers
Retinix AI doesn't just diagnose, it localizes pathologies on specific retinal layers.
*Detection accuracy based on internal evaluation from pilot implementations. Full validation – in clinical trials.
Platform development directions
Developing the platform as a single AI tool for all ophthalmology. Each module uses a common core and report format.
Retinix in clinics
Practical application of the AI assistant in the daily work of ophthalmologists.
What colleagues say
In our practice, we use the Retinix platform — it is a highly convenient tool in the hands of a practicing physician. Well-annotated biomarkers allow us to quickly focus on the pathology and proceed to its solution. This platform truly simplifies and accelerates the daily workflow.
Recognized by the professional community
Who is behind Retinix
Ophthalmologists, ML engineers, and the product team — together with leading clinical consultants.
Contacts & Demo Request
Contact us for demo access or consultation on integrating the Retinix platform into your clinic's workflow.
Direct Channels
Moskovskaya st., 2 JSC Retinix INN 5034071640, OGRN 1255000060590
What is included in the demo?
- AI analysis testing on actual OCT scans from your equipment
- Second opinion report for 24 biomarkers generated in 20 seconds
- Consultation with our medical experts and efficiency evaluation
- Secure pilot implementation without transmitting personal patient data
If your email client did not open automatically, simply copy our email address or give us a call.